High concentrations of tissue inhibitor of metalloproteinases-1 (TIMP-1) in serum of patients with systemic sclerosis - An association with organ involvement;Wysokie stȩżenia tkankowego inhibitora metaloproteaz 1 (TIMP-1) w surowicy krwi chorych na twardzinȩ układowa̧ - Zwia̧zek z obecnościa̧ zmian narza̧dowych

Przeglad Dermatologiczny

Volumn 91, Issue 6, 2004, Pages 467-474

  Bogaczewicz, Jarosław ^a   Krasowska, Dorota ^b   Stryjecka Zimmer, Marta ^a   Chodorowska, Grazyna ^b  

^a Dzieciȩcej AM ^*  (Poland)

^b Katedra i Klinika Dermatologii   (Poland)

Author keywords

Extracellular matrix; Matrix metalloproteinases; Systemic sclerosis; TIMP 1; Tissue inhibitors of metalloproteinases

Indexed keywords

COLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; EXTRACELLULAR MATRIX; FEMALE; HEART ARRHYTHMIA; HUMAN; LUNG DISEASE; PROTEIN EXPRESSION; SCLERODERMA; SKIN; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS;

EID: 13244298532     PISSN: 00332526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Błaszczyk M., Jarza̧bek-Chorzelska M., Jabłoń ska S. i inni: Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations. Br J Dermatol 1990, 123, 421-430.
2. Black C.M.: The aetiopathogenesis of systemic sclerosis. J Intern Med 1993, 234, 3-8.
3. Mauch C., Eckes B., Hunzelmann N. i inni: Control of fibrosis in systemic scleroderma. J Invest Dermatol 1993, 100, 92-96.
4. Kuroda K., Shinkai H.: Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res 1997, 289, 567-572.
5. Bou-Gharios G., Osman J., Black C. i inni: Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis. Clin Chim Acta 1994, 231, 69-78.
6. Nagase H., Woessner J.F. Jr: Matrix metalloproteinases. J Biol Chem 1999, 274, 21491-21494.
7. Gross J., Lapiere C.M.: Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 1962, 48, 1014-1022.
8. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w gojeniu siȩ ran skóry. Przegl Dermatol 2004, 91, 253-261.
9. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w starzeniu siȩ słonecznym skóry. Przegl Dermatol 2004, 91, 163-168.
10. Kirk T.Z., Mark M.E., Chua C.C. i inni: Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 1995, 270, 3423-3428.
11. Hayakawa T., Yamashita K., Tanzawa K. i inni: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992, 298, 29-32.
12. Kikuchi K., Kadono T., Furue M. i inni: Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. J Invest Dermatol 1997, 108, 281-284.
13. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w twardzinie nkładowej. Przegl Dermatol 2003, 90, 373-381.
14. Kikuchi K., Kubo M., Sato S., Fujimoto M., Tamaki K.: Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J Am Acad Dermatol 1995, 33, 973-978.
15. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23, 581-590.
16. LeRoy E.C., Black C., Fleischmajer R. i inni: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15, 202-205.
17. Clements P.J., Lachenbruch P.A., Seibold J.R. i inni: Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993, 20, 1892-1896.
18. Steen V.D., Powell D.L., Medsger T.A. Jr: Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988, 31, 196-203.
19. Steen V.: Predictors of end stage lung disease in systemic sclerosis. Ann Rheum Dis. 2003, 62, 97-99.
20. Medsger T.A. Jr, Silman A.J., Steen V.D. i inni: A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999, 26, 2159-2167.
21. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w progresji nowotworów skóry a nowe strategie farmakologicznej inhibicji metaloproteaz macierzy. Przegl Dermatol 2004, 91, 153-160.
22. Carmichael D.F., Sommer A., Thompson R.C. i inni: Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Nat Acad Sci 1986, 83, 2407-2411.
23. Brew K., Dinakarpandian D., Nagase H.: Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000, 1477, 267-283.
24. Docherty A.J., Lyons A., Smith B.J. i inni: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985, 318, 66-69.
25. Chester L., Golde D.W., Bersch N. i inni: Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood 1995, 86, 4506-4515.
26. Zhao W.Q., Li H., Yamashita K. i inni: Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J Cell Sci 1998, 111, 1147-1153.
27. Ritter L.M., Garfield S.H., Thorgeirsson U.P.: Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. Biochem Biophys Res Commun 1999, 257, 494-499.
28. Young-Min S.A., Beeton C., Laughton R. i inni: Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis 2001, 60, 846-518.
29. Kuroda K., Shinkai H.: Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res 1997, 289, 567-572.
30. Fraser J.K., Lin F.K., Berridge M.V.: Expression and modulation of specific, high affinity binding sites for erythropoietin on the human erythroleukemic cell line K562. Blood 1988, 71, 104-109.
31. Lightfoot B.O., Mulloy L.L., Jagadeesan M. i inni: ACEi-induced attenuation of platelet TIMP-1 production in renal allograft recipients. Possible impact on erythropoiesis. Transplant Proc 2002, 34, 1806-1807.
32. Klimiuk P.A., Sierakowski S., Chwiećko J.: Stȩżenie interleukiny 6 (IL-6) w surowicy krwi koreluje ze stȩżeniem metaloproteinaz i ich tkankowych inhibitorów w reumatoidalnym zapaleniu stawów. Pol Arch Med Wewn 2003, 109, 119-123.
33. Błaszczyk M., Jarza̧bek-Chorzelska M., Jabłoń ska S. i inni: Markery immunologiczne twardziny. Medipress Dermatologia 1996, 3, 8-12.
34. Sato S., Hayakawa I., Hasegawa M. i inni: Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Invest Dermatol 2003, 120, 542-547.
35. Murphy G., Reynolds J.J., Werb Z.: Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem 1985, 260, 3079-3083.
36. Lotz M., Guerne P.A.: Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991, 266, 2017-2020.
37. Chua C.C., Chua B.H.: Tumor necrosis factor-alpha induces mRNA for collagenase and TIMP in human skin fibroblasts. Connect Tissue Res 1990, 25, 161-170.
38. Wright J.K., Cawston T.E., Hazleman B.L.: Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts. Biochim Biophys Acta 1991, 1094, 207-210.
39. Cotton S.A., Herrick A.L., Jayson M.I. i inni: TGF beta - a role in systemic sclerosis? J Pathol 1998, 184, 4-6.